Company profile
Drugs for Neglected Diseases initiative (DNDi)
International non-profit developing safe, effective, and affordable treatments for the most neglected patients.
- Industry
- Research Services
- Employees
- 431
- Headquarters
- Geneva
- Founded
- 2003
- Office locations
- 8
Drugs for Neglected Diseases initiative (DNDi) company summary
Drugs for Neglected Diseases initiative (DNDi) is a company in the Research Services industry, headquartered in Geneva, founded in 2003. On LinkedIn the company has around 431 employees. The company lists 8 office locations. Its listed specialties include neglected diseases, drug development, leishmaniasis, human African trypanosomiasis, Chagas disease.
What technology does Drugs for Neglected Diseases initiative (DNDi) use?
No technologies detected yet. Warmrank rechecks company websites on a rolling basis.
About Drugs for Neglected Diseases initiative (DNDi)
The Drugs for Neglected Diseases initiative (DNDi) is an international, not-for-profit research and development organization. We discover, develop, and deliver treatments for neglected patients around the world. Our treatments are affordable and patient-friendly – and have already saved millions of lives. We are researching new treatments for people living with Chagas disease, sleeping sickness (human African trypanosomiasis), leishmaniasis, filarial infections, mycetoma, paediatric HIV, hepatitis C, and dengue. Together with our partners, we are working on over 40 projects, including more than 20 new chemical entities. We are also running over 20 clinical trials. When the medical humanitarian organization Médecins Sans Frontières (MSF) won the Nobel Peace Prize in 1999, they dedicated a portion of the award to addressing this fatal imbalance and exploring a new, alternative, not-for-profit model for developing drugs for neglected patients. As a result in 2003, MSF, the World Health Organization, and five international research institutions founded DNDi.
Specialties
Where is Drugs for Neglected Diseases initiative (DNDi) located?
Drugs for Neglected Diseases initiative (DNDi) lists 8 office locations.
Compare companies similar to Drugs for Neglected Diseases initiative (DNDi)
More companies in Research Services.
| Company | Industry | Employees | Founded | Headquarters |
|---|---|---|---|---|
Drugs for Neglected Diseases initiative (DNDi) dndi.org | Research Services | 431 | 2003 | Geneva |
 Google DeepMind deepmind.google | Research Services | 10,044 | 2010 | London, London, GB |
 PPD ppd.com | Research Services | 20,326 | - | Waltham, Massachusetts |
 Sony Research India sonyresearchindia.com | Research Services | 79 | 2020 | Bengaluru, Karnataka |
 CERN home.cern | Research Services | 8,126 | 1954 | Meyrin, Genève |
 NIH Innovates nih.gov | Research Services | 1,536 | - | Bethesda, MD |
| Research Services | 4,981 | 1901 | Gaithersburg, MD | |
 Forrester forrester.com | Research Services | 1,651 | - | Cambridge, MA |
 CSIRO csiro.au | Research Services | 6,785 | - | Acton, ACT |
 European Research Council (ERC) europa.eu | Research Services | 582 | 2007 | Saint-Josse-ten-Noode, Brussels |
| Research Services | 4,739 | 1916 | Ottawa, Ontario |
Frequently asked questions about Drugs for Neglected Diseases initiative (DNDi)
What does Drugs for Neglected Diseases initiative (DNDi) do?
The Drugs for Neglected Diseases initiative (DNDi) is an international, not-for-profit research and development organization. We discover, develop, and deliver treatments for neglected patients around the world. Our treatments are affordable and patient-friendly – and have already saved millions of lives. We are researching new treatments for people living with Chagas disease, sleeping sickness (human African trypanosomiasis), leishmaniasis, filarial infections, mycetoma, paediatric HIV, hepatitis C, and dengue. Together with our partners, we are working on over 40 projects, including more than 20 new chemical entities. We are also running over 20 clinical trials. When the medical humanitarian organization Médecins Sans Frontières (MSF) won the Nobel Peace Prize in 1999, they dedicated a portion of the award to addressing this fatal imbalance and exploring a new, alternative, not-for-profit model for developing drugs for neglected patients. As a result in 2003, MSF, the World Health Organization, and five international research institutions founded DNDi.
How many employees does Drugs for Neglected Diseases initiative (DNDi) have?
Drugs for Neglected Diseases initiative (DNDi) has around 431 employees on LinkedIn.
Where is Drugs for Neglected Diseases initiative (DNDi) headquartered?
Drugs for Neglected Diseases initiative (DNDi) is headquartered in Geneva.
Where does Drugs for Neglected Diseases initiative (DNDi) have offices?
Drugs for Neglected Diseases initiative (DNDi) lists 8 office locations, including Geneva, 1202, CH; Centro, Rio de Janeiro, Rio de Janeiro 20010-020; Commune de la Gombe, Kinshasa 0, CD; Kuala Lumpur, Kuala Lumpur, MY; Nairobi, Kilimani 254, KE.
When was Drugs for Neglected Diseases initiative (DNDi) founded?
Drugs for Neglected Diseases initiative (DNDi) was founded in 2003.
Build a lead list from companies like Drugs for Neglected Diseases initiative (DNDi)
Describe your ICP or import a CSV. Warmrank finds matching companies, enriches contacts with verified emails, and tracks every lead.